2011 Highlights
 |
participants from all sectors of the medical research enterprise, across therapeutic areas, and across geographic boundaries |
 |
speakers who have shaped markets engaged in dynamic, candid discussions on issues that matter (75% of speakers are new to this meeting) |
 |
plenary and breakout panel discussions that focused on transformative ideas, best practices, and lessons learned |
 |
collaborative programs presented their novel approaches to commercialization, academic translational efforts, data sharing initiatives, drug repurposing programs, clinical trials innovations, and intellectual property management |
 |
experts on-site provided one-on-one pro-bono consultations with the goal of paying it forward and accelerating the process by making their expertise accessible |
 |
individual one-on-one pre-scheduled meetings that connected leaders from across sectors, disciplines, and areas of expertise |
Numerous possibilities for productive collisions and results-oriented networking |
 Priming The Pump: Filling the Therapeutic Pipeline |
 Intersection of Human, Social, and Financial Capital |
|
 Back to Basics: Patient Activism Thirty Years After HIV/AIDS |
Who Will Pay for Tomorrow's Medical Breakthroughs?
|
|
Partnering For Cures Outcomes
In its 3rd year, Partnering for Cures has led to a number of tangible successes:
- An investment partnership between a nonprofit and a biotech company that allowed for early stage research on a cancer drug candidate to move forward.
- A joint program between a pharmaceutical company and nonprofit research foundation to support novel research resulting in joint grants to three young investigators.
- A transformative partnership between two nonprofits to pool and analyze large clinical and molecular datasets to better understand disease.